Latest filing published 04 Jun 2025 for Biotage AB.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Scott Carr: trading record in brief
All filings by Scott Carr on record concern Biotage AB, in the capacity of chief executive. Over a trading history stretching from 18 July 2023 to 2 June 2025, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 4 June 2025: a share grant, in Biotage AB. Filings reach the Finansinspektionen feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Scott Carr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 297 shares0AktieISIN SE0000454746FI:A003P288-1Canonical exit: 31 Aug 2025 (T+90)
1 of 1 declaration